Skip to main content
Premium Trial:

Request an Annual Quote

Shares of Nanosphere Rebound

NEW YORK (GenomeWeb News) – Shares of molecular diagnostics firm Nanosphere rebounded today, after falling sharply earlier in the week.
Shares of the Northbrook, Ill.-based firm were up 26 percent at $6 in late Friday afternoon trade on the Nasdaq.
On Monday, Nanosphere’s stock tumbled 35 percent to close at $4.26, even though it reported no news and it didn’t make any regulatory filings that would account for such a sell-off. Some investors have speculated that hedge funds may have been selling the firm’s stock to fund redemption requests from investors.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.